Fundamental dimension Equity attribute | CRFTFPeer $0.000.00% Cap $23P/E -0.0x QuantScore37/100 | BIOCQPeer $0.00030.00% Cap $788P/E -0.0x QuantScore52/100 | BSPMLeader $0.00010.00% Cap $264P/E -0.0x QuantScore54/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
57/100 |
94/100 |
83/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 50/100 | 67/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 44/100 | 33/100 |
Growth Revenue / earnings growth & margins | 33/100 | 20/100 | 34/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -0.0x |
Forward P/E (next FY) | — | -0.0x | — |
EV / EBITDA (TTM) | -17.8x | 0.0x | -1.3x |
Price / Sales | 0.0x | 0.0x | 0.0x |
Price / Free Cash Flow | -0.0x | -0.0x | 0.0x |
PEG ratio | 0.00 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | — | 4 / 9 |
Altman Z-Score | -892.96 (Distress) | — | 0.02 (Distress) |
Total debt / equity | -0.78 | 1.37 | 0.06 |
Quick ratio | 0.0x | 2.8x | 1.3x |
Interest coverage | -2.9x | -101.2x | -17.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -92.3% | -57.8% | -91.2% |
Net income growth YoY | +87.0% | -1036.2% | +77.3% |
Gross margin (TTM) | 5.8% | -10.0% | 38.4% |
Operating margin (FY) | -2137.2% | -123.7% | -149.5% |
FCF margin (FY) | -720.6% | -54.5% | 206.1% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | +50.0% | +0.0% |
3M return | 0.0% | +200.0% | +0.0% |
6M return | 0.0% | +200.0% | +0.0% |
Year to date | 0.0% | +200.0% | +0.0% |
1Y return | 0.0% | +200.0% | +0.0% |
3Y return | -97.1% | -99.9% | 0.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-2.61 -26104170.2% premium | $-7,141.70 -2380567319.0% premium | $0.1372 +137133.3% upside |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |